Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis-Reference-Cited by-同舟云学术

Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis

Published:2019-12-24 Issue:67 Volume:10 Page:7142-7155
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tuminello Stephanie¹,Veluswamy Rajwanth¹²,Lieberman-Cribbin Wil¹,Gnjatic Sacha²³⁴,Petralia Francesca⁵,Wang Pei⁵,Flores Raja⁶,Taioli Emanuela¹⁶⁷

Affiliation:

1. Institute for Translational Epidemiology and Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA

2. Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

3. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

4. Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

5. Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA

6. Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC;Exploration of Targeted Anti-tumor Therapy;2024-07-19

2. Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma;Lung Cancer;2024-06

3. Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer;The Journal of Pathology;2024-01-17

4. Identification of the prognosis value of pyroptosis related genes in the NSCLC;2024-01-10

5. Research Progress of EGFR-TKIs Resistance and PD-L1 Expression in EGFR-Mutant Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024